Trilantic North America Makes Minority Investment in Rarebreed Veterinary Partners

September 28, 2020

Trilantic North America closed a substantial minority investment in Rarebreed Veterinary Partners, a Portland, Maine–based, technology-enabled veterinary services platform. The investment will fund Rarebreed's growth plan; co-founders Dan Espinal and Sean Miller retain meaningful equity and will continue to lead the business. Existing equity investors Caremi Investments, Northwood Ventures and Halle Capital Management also participated in the financing round.

Buyers
Trilantic North America, Caremi Investments, Northwood Ventures, Halle Capital Management
Targets
Rarebreed Veterinary Partners
Location
Maine, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.